{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:21:11Z","timestamp":1770470471475,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017590","name":"Universit\u00e4tsklinikum Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100017590","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>LHON leads to gradual, painless, and permanent vision loss in both eyes, often associated with central scotomas. As the condition progresses, there is a decline in visual function, accompanied by noticeable structural alterations. This study focused on evaluating the clinical characteristics of patients with differing LHON stages, with a specific emphasis on optical coherence tomography (OCT) imaging results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This analysis included 22 individuals with LHON. Patients underwent thorough clinical ophthalmologic assessments, including SD-OCT, Visual evoked potentials, and perimetry. When LHON was suspected, blood samples were obtained to test for the three major mitochondrial mutations (G1178A, T14484C, G3460A), with further sequencing to identify additional known mutations. The data were subsequently examined through descriptive statistical methods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The clinical characteristics of 22 individuals (median age 33, range 9\u201368) were examined. All participants carried a mutation linked to LHON. The most prevalent mutation was G11778A (55%), followed by G3460A (23%), T14484C (14%), with one instance each of the rare G13042A and C3461T mutations. Fourteen participants experienced acute vision loss (average duration: 5.2\u2009\u00b1\u20095 months), while eight had chronic LHON. There was no significant difference in visual acuity (VA, logMAR) between the two groups (0.9 vs. 0.9, <jats:italic>p<\/jats:italic>\u2009=\u20090.91). However, chronic patients exhibited significantly reduced the retinal nerve fiber layer (RNFL), especially in the temporal region (32\u00a0\u03bcm vs. 56\u00a0\u03bcm, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), but not in the nasal region. Ganglion cell layer (GCL) thickness was also notably thinner in the temporal area for chronic patients compared to those with acute LHON (22\u00a0\u03bcm vs. 28\u00a0\u03bcm, <jats:italic>p<\/jats:italic>\u2009=\u20090.04). Linear regression analysis showed correlations between RNFL and GCL and visual acuity (R\u00b2 = 0.18, <jats:italic>p<\/jats:italic>\u2009=\u20090.007 and R\u00b2 = 0.1, <jats:italic>p<\/jats:italic>\u2009=\u20090.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>In our analysis, we observed an unusual pattern in the genetic mutations, with G3460A being the second most frequent, rather than T14484C, which may be attributed to the limited sample size. 14 patients experienced acute or subacute vision loss, while eight were assessed for chronic disease. Those with chronic LHON demonstrated significantly thinner GCL and RNFL. These results underscore the importance of accelerating both diagnosis and treatment to facilitate prompt intervention for patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12886-025-03991-3","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T10:23:35Z","timestamp":1744107815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alterations in ganglion cell and nerve fiber layer in Leber hereditary optic neuropathy across clinical stages"],"prefix":"10.1186","volume":"25","author":[{"given":"Michael","family":"Oeverhaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareile","family":"Knetsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Jabbarli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Nolden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos E.","family":"Bechrakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Rating","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"3991_CR1","unstructured":"Leber T. Ueber heredit\u00e4re und congenital-angelegte Sehnervenleiden| EndNote Click. Accessed February 8, 2024. https:\/\/click.endnote.com\/viewer?doi=10.1007%2Fbf01694557_token=WzM3Nzc3MDcsIjEwLjEwMDcvYmYwMTY5NDU1NyJd.d27Bap7bH8xK4eou9sTAozVMnq0"},{"issue":"3","key":"3991_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ajo.2005.03.017","volume":"140","author":"NJ Newman","year":"2005","unstructured":"Newman NJ. Hereditary optic neuropathies: from the mitochondria to the optic nerve. Am J Ophthalmol. 2005;140(3):517\u201323. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.017.","journal-title":"Am J Ophthalmol"},{"issue":"2\u20132","key":"3991_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies \u2013 Disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2\u20132):81\u2013114. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"3991_CR4","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/s0161-6420(96)30665-9","volume":"103","author":"EK Nikoskelainen","year":"1996","unstructured":"Nikoskelainen EK, Huoponen K, Juvonen V, Lamminen T, Nummelin K, Savontaus ML. Ophthalmologic findings in Leber hereditary optic neuropathy, with special reference to mtDNA mutations. Ophthalmology. 1996;103(3):504\u201314. https:\/\/doi.org\/10.1016\/s0161-6420(96)30665-9.","journal-title":"Ophthalmology"},{"issue":"1","key":"3991_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","volume":"23","author":"V Carelli","year":"2004","unstructured":"Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res. 2004;23(1):53\u201389. https:\/\/doi.org\/10.1016\/j.preteyeres.2003.10.003.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"3991_CR6","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1086\/501236","volume":"78","author":"V Carelli","year":"2006","unstructured":"Carelli V, Achilli A, Valentino ML, et al. Haplogroup effects and recombination of mitochondrial DNA: novel clues from the analysis of Leber hereditary optic neuropathy pedigrees. Am J Hum Genet. 2006;78(4):564\u201374. https:\/\/doi.org\/10.1086\/501236.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3991_CR7","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/brain\/awp158","volume":"132","author":"MA Kirkman","year":"2009","unstructured":"Kirkman MA, Yu-Wai-Man P, Korsten A, et al. Gene\u2013environment interactions in Leber hereditary optic neuropathy. Brain. 2009;132(9):2317\u201326. https:\/\/doi.org\/10.1093\/brain\/awp158.","journal-title":"Brain"},{"issue":"3","key":"3991_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ophtha.2009.07.026","volume":"117","author":"P Barboni","year":"2010","unstructured":"Barboni P, Carbonelli M, Savini G, et al. Natural history of Leber\u2019s hereditary optic neuropathy: longitudinal analysis of the retinal nerve fiber layer by optical coherence tomography. Ophthalmology. 2010;117(3):623\u20137. https:\/\/doi.org\/10.1016\/j.ophtha.2009.07.026.","journal-title":"Ophthalmology"},{"issue":"7","key":"3991_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1001\/archopht.1984.01040030783017","volume":"102","author":"E Nikoskelainen","year":"1984","unstructured":"Nikoskelainen E, Hoyt WF, Nummelin K, Schatz H. Fundus findings in Leber\u2019s hereditary optic neuroretinopathy. III. Fluorescein angiographic studies. Arch Ophthalmol. 1984;102(7):981\u20139. https:\/\/doi.org\/10.1001\/archopht.1984.01040030783017.","journal-title":"Arch Ophthalmol"},{"issue":"Pt 2","key":"3991_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/brain\/118.2.319","volume":"118","author":"P Riordan-Eva","year":"1995","unstructured":"Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, Da Costa J, Harding AE. The clinical features of Leber\u2019s hereditary optic neuropathy defined by the presence of a pathogenic mitochondrial DNA mutation. Brain. 1995;118(Pt 2):319\u201337. https:\/\/doi.org\/10.1093\/brain\/118.2.319.","journal-title":"Brain"},{"key":"3991_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3389\/fneur.2014.00141","volume":"5","author":"C La Morgia","year":"2014","unstructured":"La Morgia C, Carbonelli M, Barboni P, Sadun AA, Carelli V. Medical Management of Hereditary Optic Neuropathies. Front Neurol. 2014;5:141. https:\/\/doi.org\/10.3389\/fneur.2014.00141.","journal-title":"Front Neurol"},{"issue":"4","key":"3991_CR12","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1097\/WNO.0000000000001023","volume":"40","author":"CB Catarino","year":"2020","unstructured":"Catarino CB, von Livonius B, Priglinger C, et al. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy. J Neuroophthalmol. 2020;40(4):558\u201365. https:\/\/doi.org\/10.1097\/WNO.0000000000001023.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"3991_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/jimd.12699","volume":"47","author":"N Keshavan","year":"2024","unstructured":"Keshavan N, Minczuk M, Viscomi C, Rahman S. Gene therapy for mitochondrial disorders. J Inherit Metab Dis. 2024;47(1):145\u201375. https:\/\/doi.org\/10.1002\/jimd.12699.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"3991_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/WNO.0000000000001367","volume":"41","author":"V Biousse","year":"2021","unstructured":"Biousse V, Newman NJ, Yu-Wai-Man P, et al. Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. J Neuroophthalmol. 2021;41(3):309\u201315. https:\/\/doi.org\/10.1097\/WNO.0000000000001367.","journal-title":"J Neuroophthalmol"},{"issue":"2","key":"3991_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40259-021-00468-9","volume":"35","author":"C Vignal-Clermont","year":"2021","unstructured":"Vignal-Clermont C, Girmens JF, Audo I, et al. Safety of Intravitreal Gene Therapy for Treatment of Subjects with Leber Hereditary Optic Neuropathy due to Mutations in the Mitochondrial ND4 Gene: The REVEAL Study. BioDrugs. 2021;35(2):201\u201314. https:\/\/doi.org\/10.1007\/s40259-021-00468-9.","journal-title":"BioDrugs"},{"issue":"1","key":"3991_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ophtha.2004.06.034","volume":"112","author":"P Barboni","year":"2005","unstructured":"Barboni P, Savini G, Valentino ML, et al. Retinal nerve fiber layer evaluation by optical coherence tomography in Leber\u2019s hereditary optic neuropathy. Ophthalmology. 2005;112(1):120\u20136. https:\/\/doi.org\/10.1016\/j.ophtha.2004.06.034.","journal-title":"Ophthalmology"},{"issue":"9","key":"3991_CR17","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1136\/bjophthalmol-2015-307326","volume":"100","author":"N Balducci","year":"2016","unstructured":"Balducci N, Savini G, Cascavilla ML, et al. Macular nerve fibre and ganglion cell layer changes in acute Leber\u2019s hereditary optic neuropathy. Br J Ophthalmol. 2016;100(9):1232\u20137. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307326.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"3991_CR18","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1038\/s41433-019-0695-5","volume":"34","author":"F Darvizeh","year":"2020","unstructured":"Darvizeh F, Asanad S, Falavarjani KG, et al. Choroidal thickness and the retinal ganglion cell complex in chronic Leber\u2019s hereditary optic neuropathy: a prospective study using swept-source optical coherence tomography. Eye (Lond). 2020;34(9):1624\u201330. https:\/\/doi.org\/10.1038\/s41433-019-0695-5.","journal-title":"Eye (Lond)"},{"issue":"3","key":"3991_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities hand motion and counting fingers can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236\u201340. https:\/\/doi.org\/10.1167\/iovs.05-0981.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3991_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00417-008-0926-0","volume":"247","author":"C Lange","year":"2009","unstructured":"Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories hand motion and counting fingers using the Freiburg Visual Acuity Test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137\u201342. https:\/\/doi.org\/10.1007\/s00417-008-0926-0.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"3991_CR21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1167\/iovs.15-18306","volume":"57","author":"T Rosenberg","year":"2016","unstructured":"Rosenberg T, N\u00f8rby S, Schwartz M, et al. Prevalence and Genetics of Leber Hereditary Optic Neuropathy in the Danish Population. Invest Ophthalmol Vis Sci. 2016;57(3):1370. https:\/\/doi.org\/10.1167\/iovs.15-18306.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3991_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ophtha.2019.11.014","volume":"127","author":"L Poincenot","year":"2020","unstructured":"Poincenot L, Pearson AL, Karanjia R. Demographics of a Large International Population of Patients Affected by Leber\u2019s Hereditary Optic Neuropathy. Ophthalmology. 2020;127(5):679\u201388. https:\/\/doi.org\/10.1016\/j.ophtha.2019.11.014.","journal-title":"Ophthalmology"},{"issue":"3","key":"3991_CR23","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1442-9071.1992.tb00937.x","volume":"20","author":"DA Mackey","year":"1992","unstructured":"Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol. 1992;20(3):177\u201384. https:\/\/doi.org\/10.1111\/j.1442-9071.1992.tb00937.x.","journal-title":"Aust N Z J Ophthalmol"},{"key":"3991_CR24","doi-asserted-by":"crossref","unstructured":"Man PYW, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England. Am J Hum Genet. Published online 2003.","DOI":"10.1086\/346066"},{"issue":"2","key":"3991_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","volume":"30","author":"P Yu-Wai-Man","year":"2011","unstructured":"Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies \u2013 Disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30(2):81\u2013114. https:\/\/doi.org\/10.1016\/j.preteyeres.2010.11.002.","journal-title":"Prog Retin Eye Res"},{"key":"3991_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/B978-0-12-821751-1.00010-5","volume":"194","author":"V Carelli","year":"2023","unstructured":"Carelli V, La Morgia C, Yu-Wai-Man P. Mitochondrial optic neuropathies. Handb Clin Neurol. 2023;194:23\u201342. https:\/\/doi.org\/10.1016\/B978-0-12-821751-1.00010-5.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"3991_CR27","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1442-9071.1996.tb01545.x","volume":"24","author":"C Chan","year":"1996","unstructured":"Chan C, Mackey DA, Byrne E. Sporadic Leber hereditary optic neuropathy in Australia and New Zealand. Aust N Z J Ophthalmol. 1996;24(1):7\u201314. https:\/\/doi.org\/10.1111\/j.1442-9071.1996.tb01545.x.","journal-title":"Aust N Z J Ophthalmol"},{"issue":"6","key":"3991_CR28","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1080\/02713683.2019.1567792","volume":"44","author":"S Asanad","year":"2019","unstructured":"Asanad S, Tian JJ, Frousiakis S, et al. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber\u2019s Hereditary Optic Neuropathy and Dominant Optic Atrophy. Curr Eye Res. 2019;44(6):638\u201344. https:\/\/doi.org\/10.1080\/02713683.2019.1567792.","journal-title":"Curr Eye Res"},{"issue":"20","key":"3991_CR29","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.3390\/jcm11206045","volume":"11","author":"S Petrovic Pajic","year":"2022","unstructured":"Petrovic Pajic S, Lapajne L, Vratanar B, et al. The Relative Preservation of the Central Retinal Layers in Leber Hereditary Optic Neuropathy. JCM. 2022;11(20):6045. https:\/\/doi.org\/10.3390\/jcm11206045.","journal-title":"JCM"},{"issue":"1","key":"3991_CR30","doi-asserted-by":"publisher","first-page":"12069","DOI":"10.1038\/s41598-024-62704-w","volume":"14","author":"HJ Joo","year":"2024","unstructured":"Joo HJ, Moon Y, Jung JH. Variability of relationship between inner-retinal structural changes and visual dysfunction in optic neuropathy. Sci Rep. 2024;14(1):12069. https:\/\/doi.org\/10.1038\/s41598-024-62704-w.","journal-title":"Sci Rep"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-025-03991-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-025-03991-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T10:23:36Z","timestamp":1744107816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-025-03991-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3991"],"URL":"https:\/\/doi.org\/10.1186\/s12886-025-03991-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Duisburg-Essen (Reference Number: 23-11110-BO). All data were anonymized, and the requirement for informed consent was waived due to the retrospective nature of the study. The blood samples were obtained during the original clinical routine diagnostic workup and not as part of a study. Solely, the results were analyzed as any other clinical routine assessments. Therefore, it was regarded as retrospective by the Essen Ethics Committee and the need for an informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"183"}}